PHP39 Toward a Better Drug Pricing Policy in Korea: Links Between Price Regulation and R&D Activities

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.590
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

2018 Japan Drug Pricing System Radical Reform: Toward Enhancement of Drug Price Containment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending

SSRN Electronic Journal
2006English

Late-Stage Pharmaceutical R&D and Pricing Policies Under Two-Stage Regulation

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
2016English

The Impact of Generic Drug Policy on Drug Pricing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Better Data, Better Policy and Better Lives: A Call for Improved Drug Monitoring and Concerted Responses

Addiction
MedicinePsychiatryMental Health
2019English

Collaborative R&D and Pricing Policy of Supply Chain Under the Selection Behavior of Heterogeneous Customer

Mathematical Problems in Engineering
MathematicsEngineering
2019English

Input Price Discrimination and Upstream R&D Investments

Review of Industrial Organization
ManagementEconomicsOrganizational BehaviorHuman Resource ManagementStrategyInnovationManagement of TechnologyEconometrics
2019English

Technological Outsourcing in Corporate R&D Activities

Tetsu-To-Hagane/Journal of the Iron and Steel Institute of Japan
AlloysCondensed Matter PhysicsMetalsTheoretical ChemistryMaterials ChemistryPhysical
2004English

International R&D Tournaments and Industrial Policy

Journal of Economic Integration
EconomicsEconometricsFinance
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy